GB2303303B - Medical treatment - Google Patents

Medical treatment

Info

Publication number
GB2303303B
GB2303303B GB9614578A GB9614578A GB2303303B GB 2303303 B GB2303303 B GB 2303303B GB 9614578 A GB9614578 A GB 9614578A GB 9614578 A GB9614578 A GB 9614578A GB 2303303 B GB2303303 B GB 2303303B
Authority
GB
United Kingdom
Prior art keywords
medical treatment
medical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9614578A
Other versions
GB2303303A (en
GB9614578D0 (en
Inventor
Colin Trevor Dourish
Allan Fletcher
Paul John Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of GB9614578D0 publication Critical patent/GB9614578D0/en
Publication of GB2303303A publication Critical patent/GB2303303A/en
Application granted granted Critical
Publication of GB2303303B publication Critical patent/GB2303303B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9614578A 1995-07-13 1996-07-11 Medical treatment Expired - Fee Related GB2303303B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9514384.8A GB9514384D0 (en) 1995-07-13 1995-07-13 Medical treatment

Publications (3)

Publication Number Publication Date
GB9614578D0 GB9614578D0 (en) 1996-09-04
GB2303303A GB2303303A (en) 1997-02-19
GB2303303B true GB2303303B (en) 1999-09-15

Family

ID=10777630

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9514384.8A Pending GB9514384D0 (en) 1995-07-13 1995-07-13 Medical treatment
GB9614578A Expired - Fee Related GB2303303B (en) 1995-07-13 1996-07-11 Medical treatment

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9514384.8A Pending GB9514384D0 (en) 1995-07-13 1995-07-13 Medical treatment

Country Status (1)

Country Link
GB (2) GB9514384D0 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999003833A1 (en) * 1997-07-15 1999-01-28 Sankyo Company, Limited Piperazine derivatives
UA66370C2 (en) 1997-12-16 2004-05-17 Lilly Co Eli Arylpiperazines having activity to setotonin 1 receptors
CA2367402C (en) 1999-03-12 2010-11-23 Basf Aktiengesellschaft Stable pharmaceutical dosage form for paroxetine anhydrate
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
EP1266659A1 (en) * 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
ITMI20021327A1 (en) * 2002-06-14 2003-12-15 Recordati Chem Pharm NEW OSSIALCHILPIPERAZINE
KR100997549B1 (en) 2005-08-15 2010-11-30 에프. 호프만-라 로슈 아게 Piperidine and piperazine derivatives as p2x3 antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
WO1996003400A1 (en) * 1994-07-26 1996-02-08 Pfizer Inc. 4-indole derivatives as serotonin agonists and antagonists
EP0722941A2 (en) * 1995-01-17 1996-07-24 Eli Lilly And Company Compounds having effects on serotonin-related systems

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
WO1996003400A1 (en) * 1994-07-26 1996-02-08 Pfizer Inc. 4-indole derivatives as serotonin agonists and antagonists
EP0722941A2 (en) * 1995-01-17 1996-07-24 Eli Lilly And Company Compounds having effects on serotonin-related systems

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TIPS, Vol. 14, July 1993, p 262 *

Also Published As

Publication number Publication date
GB2303303A (en) 1997-02-19
GB9514384D0 (en) 1995-09-13
GB9614578D0 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
GB2298440B (en) Well treatment
ZA978450B (en) Medical treatment
AU6913796A (en) Patient treatment apparatus
HUP9901089A3 (en) Medical splint
GB9519033D0 (en) Treatment
GB2303303B (en) Medical treatment
GB9521725D0 (en) Medical treatment
HUP9901448A3 (en) Novel medical use
GB9217124D0 (en) Medical treatment
GB9408084D0 (en) Medical treatment
GB9526264D0 (en) Medical treatment
GB2307858B (en) Medical treatment
GB9608631D0 (en) Medical treatment
GB9421398D0 (en) Medical treatment
ZA951421B (en) Medical treatment
GB9424728D0 (en) Medical treatment
GB9425164D0 (en) Medical treatment
GB9425773D0 (en) Medical treatment
GB9612330D0 (en) Medical treatment
GB9602728D0 (en) Medical treatment
GB9626265D0 (en) Medical treatment
GB9626859D0 (en) Medical treatment
GB9618375D0 (en) Medical treatment
GB9621327D0 (en) Medical treatment
GB9321793D0 (en) Medical treatment

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20080711